Literature DB >> 2060174

Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids.

M Bardare1, M L Bianchi, M Furia, G G Gandolini, E Cohen, A Montesano.   

Abstract

Calciotropic hormone assays and bone mineral density (BMD) evaluations were carried out on a group of 36 children affected with juvenile chronic arthritis (JCA) (13 with pauciarticular, 8 with polyarticular and 15 with systemic onset subtype) and in a matched control group. The plasma levels of calcium, phosphate and alkaline phosphatase were normal in all the groups. Basal 25-OH D plasma levels were significantly decreased both in the polyarticular and in the systemic groups; the latter showed a further decrease after 1 year. There was a significant decrease in both the basal and the 1-year plasma levels of 1-25-OH D only in the systemic group. The BMD was decreased in the systemic group alone and the percentage increase after 1 year was significantly inferior to that in the other groups and in the controls. There was a clear relationship between the decrease in hormones and the cumulative dose of steroids administered, as well as between the BMD decrease and the physical activity of the patients (according to Steinbrocker's classification).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060174

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Bone mineral density in children with juvenile chronic arthritis.

Authors:  A Cetin; R Celiker; F Dinçer; M Ariyürek
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.

Authors:  Reyhan Celiker; Serpil Bal; Aysin Bakkaloğlu; Eda Ozaydin; Turgay Coskun; Alp Cetin; Fitnat Dinçer
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

3.  Bone mineral density and bone metabolism in Duchenne muscular dystrophy.

Authors:  M L Bianchi; A Mazzanti; E Galbiati; S Saraifoger; A Dubini; F Cornelio; L Morandi
Journal:  Osteoporos Int       Date:  2003-07-29       Impact factor: 4.507

4.  Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial.

Authors:  Ruy Carrasco; Daniel J Lovell; Edward H Giannini; Carol J Henderson; Bin Huang; Sandy Kramer; Julie Ranz; James Heubi; David Glass
Journal:  Arthritis Rheum       Date:  2008-12

5.  Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis.

Authors:  C Polito; C G Strano; L Rea; M Alessio; C S Iammarrone; N Todisco; A Marotta; E Iaccarino; M Pirozzi
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

6.  Body composition in children with juvenile idiopathic arthritis: effect of dietary intake of macronutrient: results from a cross sectional study.

Authors:  Asmae Hari; Samira Rostom; Asmae Hassani; Dalal El Badri; Ilham Bouaadi; Amina Barakat; Bouchra Chkirat; Khalid Elkari; Bouchra Amine; Najia Hajjaj-Hassouni
Journal:  Pan Afr Med J       Date:  2015-03-13

7.  Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis.

Authors:  Dalal El Badri; Samira Rostom; Ilham Bouaddi; Asmae Hassani; Bouchra Chkirate; Bouchra Amine; Najia Hajjaj-Hassouni
Journal:  Pan Afr Med J       Date:  2014-02-18

8.  Prevalence of Vitamin D Deficiency in Patients Treated for Juvenile Idiopathic Arthritis and Potential Role of Methotrexate: A Preliminary Study.

Authors:  Maciej K Stawicki; Paweł Abramowicz; Adrian Góralczyk; Justyna Młyńczyk; Anna Kondratiuk; Jerzy Konstantynowicz
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

9.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.